文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

通过 CCL17-CCR4 介导的 CTL 向 NKT 细胞许可的 DC 的趋化作用实现替代性交叉启动。

Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs.

机构信息

Institute of Molecular Medicine and Experimental Immunology, Friedrich-Wilhelms-Universität, Bonn, Germany.

出版信息

Nat Immunol. 2010 Apr;11(4):313-20. doi: 10.1038/ni.1848. Epub 2010 Feb 28.


DOI:10.1038/ni.1848
PMID:20190758
Abstract

Cross-priming allows dendritic cells (DCs) to induce cytotoxic T cell (CTL) responses to extracellular antigens. DCs require cognate 'licensing' for cross-priming, classically by helper T cells. Here we demonstrate an alternative mechanism for cognate licensing by natural killer T (NKT) cells recognizing microbial or synthetic glycolipid antigens. Such licensing caused cross-priming CD8alpha(+) DCs to produce the chemokine CCL17, which attracted naive CTLs expressing the chemokine receptor CCR4. In contrast, DCs licensed by helper T cells recruited CTLs using CCR5 ligands. Thus, depending on the type of antigen they encounter, DCs can be licensed for cross-priming by NKT cells or helper T cells and use at least two independent chemokine pathways to attract naive CTLs. Because these chemokines acted synergistically, this can potentially be exploited to improve vaccinations.

摘要

交叉呈递使树突状细胞 (DC) 能够诱导细胞毒性 T 细胞 (CTL) 对细胞外抗原产生反应。DC 对交叉呈递的要求是同源“许可”,经典的是由辅助 T 细胞提供。在这里,我们通过自然杀伤 T (NKT) 细胞识别微生物或合成糖脂抗原来证明同源许可的另一种机制。这种许可导致交叉呈递 CD8alpha(+) DC 产生趋化因子 CCL17,吸引表达趋化因子受体 CCR4 的幼稚 CTL。相比之下,辅助 T 细胞许可的 DC 使用 CCR5 配体招募 CTL。因此,根据它们遇到的抗原类型,DC 可以被 NKT 细胞或辅助 T 细胞许可进行交叉呈递,并使用至少两种独立的趋化因子途径来吸引幼稚 CTL。由于这些趋化因子具有协同作用,因此可以利用这一点来改进疫苗接种。

相似文献

[1]
Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs.

Nat Immunol. 2010-2-28

[2]
Signal 0 for guided priming of CTLs: NKT cells do it too.

Nat Immunol. 2010-4

[3]
Activated NKT Cells Can Condition Different Splenic Dendritic Cell Subsets To Respond More Effectively to TLR Engagement and Enhance Cross-Priming.

J Immunol. 2015-8-1

[4]
Suppression of murine tumour growth through CD8 cytotoxic T lymphocytes via activated DEC-205 dendritic cells by sequential administration of α-galactosylceramide in vivo.

Immunology. 2017-7

[5]
Differential expression of Th2 chemokine receptors on T cells from atopic and nonatopic asthmatics in response to Der p 1-pulsed dendritic cells.

J Med Assoc Thai. 2010-1

[6]
Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1.

J Immunol. 2013-5-13

[7]
NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.

J Immunol. 2003-3-1

[8]
BCR-ABL-specific CD4 T-helper cells promote the priming of antigen-specific cytotoxic T cells via dendritic cells.

Cell Mol Immunol. 2016-5-15

[9]
Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury.

J Clin Invest. 2009-5

[10]
TRAIL/DR5 plays a critical role in NK cell-mediated negative regulation of dendritic cell cross-priming of T cells.

J Immunol. 2011-8-10

引用本文的文献

[1]
Immunopeptidomics identified antigens for mRNA-lipid nanoparticle vaccines with alpha-galactosylceramide in multiple myeloma therapy.

J Immunother Cancer. 2025-4-29

[2]
IRF4-regulated transcriptional and functional heterogeneity of lung-resident CD11b+ cDC2 subsets during influenza virus infection.

J Immunol. 2025-5-1

[3]
New insights on anti-tumor immunity of CD8 T cells: cancer stem cells, tumor immune microenvironment and immunotherapy.

J Transl Med. 2025-3-17

[4]
Ezh2 Shapes T Cell Plasticity to Drive Atherosclerosis.

Circulation. 2025-5-13

[5]
The role of mRNA-galsomes and LNPs in enhancing HIV-specific T cell responses across various lymphoid organs.

Mol Ther Nucleic Acids. 2024-10-28

[6]
CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy.

Clin Rev Allergy Immunol. 2024-6

[7]
invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies.

Front Transplant. 2024-5-6

[8]
CD1 molecules: Beyond antigen presentation.

Mol Immunol. 2024-6

[9]
Immunity from NK Cell Subsets Is Important for Vaccine-Mediated Protection in HPV+ Cancers.

Vaccines (Basel). 2024-2-17

[10]
Rapid protection against viral infections by chemokine-accelerated post-exposure vaccination.

Front Immunol. 2024

本文引用的文献

[1]
Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands.

EMBO J. 2009-11-18

[2]
Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells.

Eur J Immunol. 2009-9

[3]
Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury.

J Clin Invest. 2009-5

[4]
Human memory CCR4+CD8+ T cell subset has the ability to produce multiple cytokines.

Int Immunol. 2009-5

[5]
Orchestrating the orchestrators: chemokines in control of T cell traffic.

Nat Immunol. 2008-9

[6]
The kidney-renal lymph node-system contributes to cross-tolerance against innocuous circulating antigen.

J Immunol. 2008-1-15

[7]
iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity.

J Immunol. 2007-10-1

[8]
Efficient, one-pot syntheses of biologically active alpha-linked glycolipids.

Chem Commun (Camb). 2007-6-21

[9]
Germline-encoded recognition of diverse glycolipids by natural killer T cells.

Nat Immunol. 2007-10

[10]
Synthesis and evaluation of stimulatory properties of Sphingomonadaceae glycolipids.

Nat Chem Biol. 2007-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索